Moutih Rafei
Chief Tech/Sci/R&D Officer en DEFENCE THERAPEUTICS INC. .
Fortuna: 87 500 $ al 31/03/2024
Perfil
Moutih Rafei is the founder of Axiom Services, Inc., IntelliStem Technologies, Inc. He is currently working as the Chief Scientific Officer & Director at Defence Therapeutics Inc. Additionally, he holds the position of Professor & Principal Investigator at the University of Montréal.
Dr. Rafei obtained his doctorate degree from McGill University in 2009.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
02/11/2023 | 70 000 ( 0.16% ) | 87 500 $ | 31/03/2024 |
Cargos activos de Moutih Rafei
Empresas | Cargo | Inicio |
---|---|---|
DEFENCE THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 09/10/2020 |
University of Montréal | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Moutih Rafei.
Empresas | Cargo | Fin |
---|---|---|
IntelliStem Technologies, Inc.
IntelliStem Technologies, Inc. BiotechnologyHealth Technology IntelliStem Technologies, Inc. is a Canadian biotechnology company that specializes in engineering stem cells for the development of next-generation cell therapy products. The private company is based in Toronto, Canada. The company's proprietary cell platforms, including Super Sentinel Cells (SSCs) for cancer therapeutics and IntelliCells for drug discovery and target identification, are genetically engineered. IntelliStem is currently moving into human clinical trials. The company was founded by Riam Shammaa, who has been the CEO since incorporation. | Founder | 01/08/2023 |
Formación de Moutih Rafei.
McGill University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
DEFENCE THERAPEUTICS INC. | Health Technology |
Empresas privadas | 1 |
---|---|
IntelliStem Technologies, Inc.
IntelliStem Technologies, Inc. BiotechnologyHealth Technology IntelliStem Technologies, Inc. is a Canadian biotechnology company that specializes in engineering stem cells for the development of next-generation cell therapy products. The private company is based in Toronto, Canada. The company's proprietary cell platforms, including Super Sentinel Cells (SSCs) for cancer therapeutics and IntelliCells for drug discovery and target identification, are genetically engineered. IntelliStem is currently moving into human clinical trials. The company was founded by Riam Shammaa, who has been the CEO since incorporation. | Health Technology |
- Bolsa de valores
- Insiders
- Moutih Rafei